Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overexpression of CD3 eta during thymic development does not alter the negative selection process

R E Hussey1, L K Clayton, A Diener

  • 1Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.

Journal of Immunology (Baltimore, Md. : 1950)
|February 15, 1993
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inequality-related economic burden of communicable diseases in Canada.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Approaches to modelling radioactive contaminations in forests - Overview and guidance.

Journal of environmental radioactivity·2017
Same author

Tests of a novel sensor for α-spectrometry in drinking water matrices.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2015
Same author

Structure of selenium incorporated in pyrite and mackinawite as determined by XAFS analyses.

Journal of contaminant hydrology·2012
Same author

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

Current cancer drug targets·2011
Same author

Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.

Oncogene·2009

Overexpressing CD3 eta in transgenic mice did not alter thymocyte development or T-cell selection. These findings suggest CD3 eta is not a limiting factor in negative selection during T-cell development.

Area of Science:

  • Immunology
  • T-cell development
  • Molecular immunology

Background:

  • The CD3 complex is crucial for T-cell receptor (TCR) signaling.
  • The specific role of the CD3 eta (CD3η) chain in thymic development and T-cell selection remains unclear.

Purpose of the Study:

  • To investigate the function of CD3 eta in thymic development.
  • To determine if CD3 eta participates in the negative selection of T-cells.

Main Methods:

  • Generation of transgenic (tg) mice overexpressing CD3 eta using a Thy-1 promoter.
  • Immunohistochemical staining and flow cytometry to analyze thymocyte populations.
  • Biochemical studies to assess TCR-associated CD3 complexes.
  • In vivo DNA fragmentation assays to evaluate negative selection.

Related Experiment Videos

Main Results:

  • CD3 eta was significantly overexpressed in cortical and medullary thymocytes of tg mice.
  • tg mice showed increased TCR surface levels and altered CD3 zeta-eta and CD3 eta-eta dimers.
  • No significant changes were observed in thymocyte subset proportions or peripheral T-cell numbers.
  • Negative selection induction via anti-CD3 epsilon treatment was comparable between tg and normal littermates.

Conclusions:

  • CD3 eta overexpression does not impact thymocyte development or T-cell subset distribution.
  • The data indicate that CD3 eta is not a rate-limiting component in the T-cell negative selection process.